Forskolin attenuates the NLRP3 inflammasome activation and IL-1β secretion in human macrophages
- 13 May 2019
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 86 (6) , 692-698
Abstract
The treatment of nucleotide-binding domain and leucine-rich repeat containing family, pyrin domain containing 3 (NLRP3) inflammasome-mediated pediatric inflammatory diseases is challenging. Here we studied whether cyclic adenosine monophosphate (cAMP) elevator forskolin could attenuate the nigericin-induced NLRP3-inflammasome activation and interleukin-1β (IL-1β) secretion in human macrophages. The proteins and messenger RNA (mRNA) levels of inflammasome structural proteins and proinflammatory cytokines were measured in forskolin-stimulated nigericin-activated human THP-1 macrophages and primary macrophages. Activation of THP-1 macrophages with nigericin increased the mRNA expression of NLRP3, IL-1β, and caspase-1 (P < 0.01). Forskolin stimulation had no effect on the mRNA expression of NLRP3, caspase-1, or IL-1β in nigericin-activated cells (P > 0.05), while their protein levels were significantly decreased (P < 0.05). Forskolin-mediated increase in cytoplasmic cAMP in non-activated cells was attenuated in nigericin-activated macrophages (P < 0.05). Basal IL-1β secretion increased from 584 to 2696 pg/mL (P < 0.01) in nigericin-activated macrophages; forskolin dose-dependently reduced the nigericin-induced secretion of mature IL-1β (P < 0.01). Forkolin also inhibited the IL-1β secretion from activated human primary macrophages. Forskolin inhibits the NLRP3 inflammasome activation and the secretion of mature IL-1β, in human macrophages. Forskolin and other cAMP elevator drugs could represent a novel approach for treatment of diseases associated with excessive inflammasome activation, like pediatric inflammatory diseases.Keywords
This publication has 20 references indexed in Scilit:
- Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human MacrophagesThe Journal of Immunology, 2015
- Initiation and perpetuation of NLRP3 inflammasome activation and assemblyImmunological Reviews, 2015
- Regulation of inflammasome activationImmunological Reviews, 2015
- MEF2 Cooperates With Forskolin/cAMP and GATA4 to Regulate Star Gene Expression in Mouse MA-10 Leydig CellsEndocrinology, 2015
- Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Activates the NLRP3 Inflammasome in Human Macrophages, Leading to the Release of Proinflammatory CytokinesInfection and Immunity, 2015
- The Prevalence and Diagnostic Utility of Systemic Inflammatory Response Syndrome Vital Signs in a Pediatric Emergency DepartmentAcademic Emergency Medicine, 2015
- Role of Innate Immunity in Neonatal InfectionAmerican Journal of Perinatology, 2013
- Ficoll-Paque™ Versus Lymphoprep™: A Comparative Study of two Density Gradient Media for Therapeutic Bone Marrow Mononuclear Cell PreparationsRegenerative Medicine, 2009
- Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 ExpressionThe Journal of Immunology, 2009
- Pannexin-1 Couples to Maitotoxin- and Nigericin-induced Interleukin-1β Release through a Dye Uptake-independent PathwayJournal of Biological Chemistry, 2007